Keyphrases
Insulin Resistance
100%
Type 2 Diabetes Mellitus (T2DM)
100%
Metformin
100%
Thiazolidinediones
100%
Hyperglycemia
15%
Pioglitazone
15%
Glycemic Control
7%
Glucose Uptake
7%
Weight Gain
7%
Insulin Concentration
7%
Cardiovascular Disease
7%
Blood Pressure
7%
Two-agent
7%
C-reactive Protein
7%
Low-density Lipoprotein
7%
Platelet Aggregation
7%
Rosiglitazone
7%
Vascular Risk
7%
Cellular Mechanisms
7%
Atherothrombotic
7%
Hepatic Glucose Production
7%
Plasminogen Activator inhibitor-1 (PAI-1)
7%
Hypoglycemia Risk
7%
Thrombotic Markers
7%
Lipid Profile
7%
Basal Insulin
7%
Low-grade Inflammation
7%
Triglycerides
7%
Overlapping Effect
7%
Vascular Adhesion Molecules
7%
Free Fatty Acids
7%
Pharmacokinetics
7%
Fatty Acid Composition
7%
Minimal Risk
7%
Adiponectin
7%
Prothrombotic Factors
7%
Complementarity Effect
7%
Nursing and Health Professions
Non Insulin Dependent Diabetes Mellitus
100%
Thiazolidinedione
100%
Insulin Resistance
100%
Metformin
100%
Hyperglycemia
15%
Pioglitazone
15%
Side Effect
7%
Cardiovascular Disease
7%
Blood Pressure
7%
Fatty Acid
7%
Hypoglycemia
7%
Rosiglitazone
7%
Cell Adhesion Proteins
7%
Adiponectin
7%
Triacylglycerol
7%
C Reactive Protein
7%
Low Density Lipoprotein
7%
Plasminogen Activator Inhibitor 1
7%
Inflammation
7%
Low Drug Dose
7%
Pharmacology, Toxicology and Pharmaceutical Science
Insulin Resistance
100%
Non Insulin Dependent Diabetes Mellitus
100%
Metformin
100%
Thiazolidinedione
100%
Hyperglycemia
15%
Pioglitazone
15%
Inflammation
7%
Fatty Acid
7%
Low Density Lipoprotein
7%
Rosiglitazone
7%
Hypoglycemia
7%
Cardiovascular Disease
7%
Side Effect
7%
Triacylglycerol
7%
Pharmacokinetics
7%
Plasminogen Activator Inhibitor 1
7%
C Reactive Protein
7%
Cell Adhesion Proteins
7%
Adiponectin
7%
Biochemistry, Genetics and Molecular Biology
Insulin Resistance
100%
Thiazolidinedione
100%
Hyperglycemia
15%
Pioglitazone
15%
Glucose Transport
7%
Cell Adhesion Proteins
7%
C-Reactive Protein
7%
Glycemic Control
7%
Low-Density Lipoprotein
7%
Triglyceride
7%
Lipid Profile
7%
Thrombocyte Aggregation
7%
Free Fatty Acids
7%
Low Drug Dose
7%
Adiponectin
7%
Plasminogen Activator Inhibitor-1
7%
Pharmacokinetics
7%
Rosiglitazone
7%
Blood Pressure
7%